Boulla LLC recalls ZoomMax Capsules
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
- Products
-
- ZoomMax Capsules
- Company
- Boulla LLC
- Where it was sold
-
Nationwide within the United States
Nationwide
- Units affected
- Unknown
- About this recall
- ZoomMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZoomMax, 2108 N St. Sacramento, CA 95816, www.zoommax.com